Vinny Motwani - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Vinny Motwani

Showing results (1-10 of 3) with videos related to

Pageof 1

Sort By:

Journal of Clinical & Cellular Immunology|November 28, 2015

T Cell Dynamic Activation and Functional Analysis in Nanoliter Droplet MicroarraySaheli Sarkar, Vinny Motwani, Pooja Sabhachandani, et al.

Molecular Cancer Therapeutics|August 25, 2017

EZH2 Inhibition by Tazemetostat Results in Altered Dependency on B-cell Activation Signaling in DLBCLDorothy Brach, Danielle Johnston-Blackwell, Allison Drew, et al.

ACS Medicinal Chemistry Letters|October 21, 2021

Discovery of a First-in-Class Inhibitor of the Histone Methyltransferase SETD2 Suitable for Preclinical StudiesJohn W Lampe, Joshua S Alford, P Ann Boriak-Sjodin, et al.

Pageof 1

Search research articles

Showing results (1-10 of 3) with videos related to

Sort By:

Pageof 1

Journal of Clinical & Cellular Immunology|November 28, 2015

T Cell Dynamic Activation and Functional Analysis in Nanoliter Droplet MicroarraySaheli Sarkar, Vinny Motwani, Pooja Sabhachandani, et al.

Molecular Cancer Therapeutics|August 25, 2017

EZH2 Inhibition by Tazemetostat Results in Altered Dependency on B-cell Activation Signaling in DLBCLDorothy Brach, Danielle Johnston-Blackwell, Allison Drew, et al.

ACS Medicinal Chemistry Letters|October 21, 2021

Discovery of a First-in-Class Inhibitor of the Histone Methyltransferase SETD2 Suitable for Preclinical StudiesJohn W Lampe, Joshua S Alford, P Ann Boriak-Sjodin, et al.

Pageof 1